Company record
Illumina, Inc.
0 FDA warning letters since 2023 and 7 recalls in the last 12 months.
Get an email the day FDA posts anything new about Illumina, Inc..
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Nov 11 | Class II | Illumina, Inc. Device |
MiSeq Dx Instrument REF: DX-410-1001 / 15036706, FOR IN VITRO DIAGNOSTIC USE (Retrospectively reported) Cybersecurity vulnerability identified in communication protocol between the customer-provided infrastructure (network storage, servers, or computers) and in vitro diagnostic devices which may result in compromised data transmission. |
| Nov 11 | Class II | Illumina, Inc. Device |
VeriSeq Onsite Server V2 REF: 20047000 (Retrospectively reported) Cybersecurity vulnerability identified in communication protocol between the customer-provided infrastructure (network storage, servers, or computers) and in vitro diagnostic devices which may result in compromised data transmission. |
| Nov 11 | Class II | Illumina, Inc. Device |
Illumina DRAGEN Server for NextSeq 550Dx REF: 20086130, (Retrospectively reported) Cybersecurity vulnerability identified in communication protocol between the customer-provided infrastructure (network storage, servers, or computers) and in vitro diagnostic devices which may result in compromised data transmission. |
| Nov 11 | Class II | Illumina, Inc. Device |
NovaSeq 6000Dx Instrument REF: 20068232, FOR IN VITRO DIAGNOSTIC USE (Retrospectively reported) Cybersecurity vulnerability identified in communication protocol between the customer-provided infrastructure (network storage, servers, or computers) and in vitro diagnostic devices which may result in compromised data transmission. |
| Nov 11 | Class II | Illumina, Inc. Device |
Nextseq 550Dx Instrument REF: 20005715, FOR IN VITRO DIAGNOSTIC USE (Retrospectively reported) Cybersecurity vulnerability identified in communication protocol between the customer-provided infrastructure (network storage, servers, or computers) and in vitro diagnostic devices which may result in compromised data transmission. |
| Oct 7 | Class II | Illumina, Inc. Device |
NovaSeq 6000Dx including DRAGEN Server, Catalog Number: 20068232; Illumina DRAGEN Server for NextSeq 550Dx, Catalog Number: 20086130 Retrospectively reported correction for an instrument intended for targeted sequencing of DNA libraries from human genomic DNA used with in vitro diagnostic assays has a server with a security vulnerability. |
| Dec 10, 2025 | Class II | Illumina, Inc. Device |
Reagent Kits/ containing flow cells, components of NextSeq 550Dx Instrument: NextSeq 550Dx High Output Reagent Kit v2.5 (75 cycles) IVD, REF: 20028870/NextSeq 550Dx HO FC Cart v2.5, 75 Cycles, REF: 20031098; NextSeq 55… An instrument intended for sequencing DNA libraries with in vitro diagnostic assays is used with reagent kits including flow cells that have flow cell gaskets that have a quality issue, which may lead to flow cell leaks during runs, which could cause run failures, that may result in: No/insufficient data output, instrument fluidics clogs, toxic substance exposure to user. |